-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Lowers Price Target to $101

Benzinga·05/12/2025 13:12:47
Listen to the news
Canaccord Genuity analyst William Plovanic maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and lowers the price target from $115 to $101.